Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel

被引:71
作者
Gloyn, AL
Cummings, EA
Edghill, EL
Harries, LW
Scott, R
Costa, T
Temple, IK
Hattersley, AT
Ellard, S
机构
[1] Peninsula Med Sch, Exeter EX2 5AX, Devon, England
[2] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada
[3] IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada
[4] Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada
[5] Univ Southampton, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England
[6] Univ Southampton, Div Human Genet, Southampton SO16 5YA, Hants, England
[7] Hosp Natl Hlth Serv Trust, Southampton SO16 5YA, Hants, England
关键词
D O I
10.1210/jc.2004-0568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activating mutations in the KCNJ11 gene encoding for the Kir6.2 subunit of the beta-cell ATP-sensitive potassium channel have recently been shown to be a common cause of permanent neonatal diabetes. In 80% of probands, these are isolated cases resulting from de novo mutations. We describe a family in which two affected paternal half-siblings were found to be heterozygous for the previously reported R201C mutation. Direct sequencing of leukocyte DNA showed that their clinically unaffected mothers and father were genotypically normal. Quantitative real-time PCR analysis of the father's leukocyte DNA detected no trace of mutant DNA. These results are consistent with the father being a mosaic for the mutation, which is restricted to his germline. This is the first report of germline mosaicism in any form of monogenic diabetes. The high percentage of permanent neonatal diabetes cases due to de novo KCNJ11 mutations suggests that germline mosaicism maybe common. The possibility of germline mosaicism should be considered when counseling recurrence risks for the parents of a child with an apparently de novo KCNJ11 activating mutation.
引用
收藏
页码:3932 / 3935
页数:4
相关论文
共 24 条
  • [1] PAX2 mutations in renal-coloboma syndrome:: mutational hotspot and germline mosaicism
    Amiel, J
    Audollent, S
    Joly, D
    Dureau, P
    Salomon, R
    Tellier, AL
    Augé, J
    Bouissou, F
    Antignac, C
    Gubler, MC
    Eccles, MR
    Munnich, A
    Vekemans, M
    Lyonnet, S
    Attié-Bitach, T
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (11) : 820 - 826
  • [2] *APPL BIOS, 2001, USER B, V1, P11
  • [3] Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β
    Bingham, C
    Ellard, S
    Allen, L
    Bulman, M
    Shepherd, M
    Frayling, T
    Berry, PJ
    Clark, PM
    Lindner, T
    Bell, GI
    Ryffel, GU
    Nicholls, AJ
    Hattersley, AT
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (03) : 898 - 907
  • [4] Association and stoichiometry of K-ATP channel subunits
    Clement, JP
    Kunjilwar, K
    Gonzalez, G
    Schwanstecher, M
    Panten, U
    AguilarBryan, L
    Bryan, J
    [J]. NEURON, 1997, 18 (05) : 827 - 838
  • [5] Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO
  • [6] 2-2
  • [7] First description of germline mosaicism in familial hypertrophic cardiomyopathy
    Forissier, JF
    Richard, P
    Briault, S
    Ledeuil, C
    Dubourg, O
    Charbonnier, B
    Carrier, L
    Moraine, C
    Bönne, G
    Komajda, M
    Schwartz, K
    Hainque, B
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (02) : 132 - 134
  • [8] Glucokinase (GCK) mutations in hyper- and hypoglycemia:: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy
    Gloyn, AL
    [J]. HUMAN MUTATION, 2003, 22 (05) : 353 - 362
  • [9] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    Gloyn, AL
    Pearson, ER
    Antcliff, JF
    Proks, P
    Bruining, GJ
    Slingerland, AS
    Howard, N
    Srinivasan, S
    Silva, JMCL
    Molnes, J
    Edghill, EL
    Frayling, TM
    Temple, IK
    Mackay, D
    Shield, JPH
    Sumnik, Z
    van Rhijn, A
    Wales, JKH
    Clark, P
    Gorman, S
    Aisenberg, J
    Ellard, S
    Njolstad, PR
    Ashcroft, FM
    Hattersley, AT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) : 1838 - 1849
  • [10] Novel mutations and a mutational hotspot in the MODY3 gene
    Glucksmann, MA
    Lehto, M
    Tayber, O
    Scotti, S
    Berkemeier, L
    Pulido, JC
    Wu, Y
    Nir, WJ
    Fang, L
    Markel, P
    Munnelly, KD
    Goranson, J
    Orho, M
    Young, BM
    Whitacre, JL
    McMenimen, C
    Wantman, M
    Tuomi, T
    Warram, J
    Forsblom, CM
    Carlsson, M
    Rosenzweig, J
    Kennedy, G
    Duyk, GM
    Krolewski, AS
    Groop, LC
    Thomas, JD
    [J]. DIABETES, 1997, 46 (06) : 1081 - 1086